Design of amphotericin B oral formulation for antifungal therapy.

Drug Delivery
Min LiuZhiwen Yang

Abstract

Amphotericin B (AmB) remains the "gold standard" for systemic antifungal therapy, even though new drugs are emerging as the attractive antifungal agents. Since AmB has negligible oral absorption as a consequence of its unfavorable physicochemical characterizations, its use is restricted to parenteral administration which is accompanied by severe side effects. As greater understanding of the gastrointestinal tract has developed, the advanced drug delivery systems are emerging with the potential to overcome the barriers of AmB oral delivery. Much research has demonstrated that oral AmB formulations such as lipid formulations may have beneficial therapeutic efficacy with reduced adverse effects and suitable for clinical application. Here we reviewed the different formulation strategies to enhance oral drug efficacy, and discussed the current trends and future perspectives for AmB oral administration in the treatment of antifungal infections.

References

Jan 7, 1999·Drug Development and Industrial Pharmacy·J S DangiV K Dixit
May 19, 2000·Antimicrobial Agents and Chemotherapy·L ZarifR J Mannino
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·R SantangeloD S Perlin
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·G DelmasD S Perlin
Dec 14, 2002·International Journal of Pharmaceutics·Y V Rama PrasadKanji Takada
Mar 5, 2003·International Journal of Pharmaceutics·O KayserS L Croft
Oct 20, 2004·Drug Development and Industrial Pharmacy·Verica RisovicKishor M Wasan
Feb 14, 2006·Mini Reviews in Medicinal Chemistry·J Golenser, A Domb
Apr 29, 2009·The Journal of Antimicrobial Chemotherapy·Pavel GershkovichKishor M Wasan
Jun 24, 2009·The Journal of Infectious Diseases·Kishor M WasanSheila J Thornton
Feb 6, 2010·Circulation Research·Dimana O MitevaMelody A Swartz
Jun 18, 2010·Natural Product Reports·Astrid A VolmerErick M Carreira
Dec 15, 2010·ACS Nano·Monica BenincasaRenato Gennaro
Apr 14, 2011·Journal of Biomedical Nanotechnology·Rahul K VermaAmit Misra
Dec 27, 2011·Journal of Biomedical Nanotechnology·Pratikkumar A Patel, Vandana B Patravale
Apr 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sóstenes MistroRoberto Badaró
Aug 1, 2012·Molecular Pharmaceutics·Sanyog JainKaushik Thanki
Nov 21, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios FarmakiotisDimitrios P Kontoyiannis
Apr 30, 2013·International Journal of Biological Macromolecules·Kuldeep SinghVikas Rana
May 31, 2013·Journal of the American Chemical Society·Brandon C WilcockMartin D Burke
Jun 4, 2013·International Journal of Pharmaceutics·Acarília Eduardo SilvaE Sócrates T Egito
Aug 21, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yancai WangDianrui Zhang
Oct 22, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea MessoriClaudio Marinai
Dec 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yuangang ZuKunlun Wang
Mar 5, 2014·The Journal of Clinical Investigation·Gwendalyn J Randolph, Norman E Miller
Jun 26, 2014·Drug Development and Industrial Pharmacy·Jo-Ann Osei-Twum, Kishor M Wasan
Jul 6, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Caroline BarauUNKNOWN Agence Nationale de Recherche sur le Sida et les hépatites (ANRS) 148 Study Group

❮ Previous
Next ❯

Citations

May 30, 2017·Journal of Chemical Theory and Computation·J M Falcón-GonzálezM Carrillo-Tripp
Oct 17, 2017·Advanced Healthcare Materials·Michelle L RataySteven R Little
Jan 8, 2020·Pharmaceutics·Célia Faustino, Lídia Pinheiro
Aug 23, 2018·Pharmaceutical Development and Technology·Janet Sui Ling TanNashiru Billa
Sep 27, 2018·European Journal of Clinical Pharmacology·Takaya UnoMitsutaka Takada
Aug 18, 2020·International Journal of Biomaterials·Merlis P Alvarez-BerriosDavid Sanchez-Rodriguez
Apr 17, 2021·Journal of Nanobiotechnology·Humzah JamshaidGul Majid Khan
Sep 4, 2020·Critical Reviews in Analytical Chemistry·Gabriel Davi MarenaMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Journal of the Oklahoma State Medical Association
H D Riley
Journal of Clinical Pharmacy and Therapeutics
C Gates, R J Pinney
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
A S O'Marcaigh, D L Betcher
© 2021 Meta ULC. All rights reserved